An Investigation on Leprosy Treatment Patterns, including Disease Prevalence, Adverse Event Monitoring, and Medication Adherence Assessment

Main Article Content

Dr. Amina Turki
Sohan Mallick
Hosne Ara Begum
Mirza Aminur Rehman
Mostakim Sk

Abstract

A prospective observational study was carried out for six months among the leprosy patients in two districts in Telanagana (Ranga Reddy and Hyderabad).The study was carried out to determine the prevalence, treatment pattern and drug related problems among the leprosy patients. During our study period 40 cases were reported from Hyderabad district and 64 from Ranga Reddy. So the prevalence of leprosy in Hyderabad and Ranga Reddy district was found to be 0.001 and 0.002 respectively. In the current study among among a total of 104 patients included, 49 (47%) were in the age group of 31-50 years. The mean age was 42.13±18.61 years. Nearly 6% of the patients were aged less than 15 showing the transmission is still going on the community. This high prevalence in younger age group calls for more vigorous means of case detection like active search for cases especially in communities known to be leprosy endemic.104 patients were enrolled in the study, of them 74(71%) were males and 30(29%) were females, demonstrating male predominance over female population. There   are   three   important   principles   for   leprosy   work   in   the future. It includes;Sustainability (new cases of leprosy are continuing and many of the consequences are lifelong so our approaches need to be sustainable) , the leprosy workers cannot do everything themselves(they need to work in alliances at all levels with other agencies, other health care workers, social services, communities, patients themselves and their families),Anti-leprosy services need to be integrated with general health and social services(this includes training, primary health care, hospital care, and community based rehabilitation) Finally we would like to emphasize the importance of a proper health education, daily ulcer care and shoe adjustments as systemic therapy and also to prevent the development of new ulcers

Downloads

Download data is not yet available.

Article Details

How to Cite
Dr. Amina Turki, Sohan Mallick, Hosne Ara Begum, Mirza Aminur Rehman, & Mostakim Sk. (2024). An Investigation on Leprosy Treatment Patterns, including Disease Prevalence, Adverse Event Monitoring, and Medication Adherence Assessment. Journal of Advanced Zoology, 45(2), 1186–1202. https://doi.org/10.53555/jaz.v45i2.4092
Section
Articles
Author Biographies

Dr. Amina Turki

Department of Pharmacy Practice, Assistant Professor,Sree Dattha Institute of Pharmacy, Sheriguda, Ibrahimpatnam, Hyderabad,Telangana, India

 

Sohan Mallick

Sree Dattha Institute of Pharmacy, Sheriguda, Ibrahimpatnam, Hyderabad,Telangana, India

Hosne Ara Begum

Sree Dattha Institute of Pharmacy, Sheriguda, Ibrahimpatnam, Hyderabad,Telangana, India

Mirza Aminur Rehman

Sree Dattha Institute of Pharmacy, Sheriguda, Ibrahimpatnam, Hyderabad,Telangana, India

Mostakim Sk

Sree Dattha Institute of Pharmacy, Sheriguda, Ibrahimpatnam, Hyderabad,Telangana, India

References

Pfaltzagraff RE, Bryceson A. Bryceson A, Pfaltzgraff RE. Leprosy. 2. ed. Churchill Livingstone: New York and Edinburg; 1979. Clinical Leprosy; pp. 15–30. [Google Scholar]

Talhari S, Penna GO, Gonçalves HS, Oliveira MLW. Talhari S, Penna GO, Gonçalves HS, Oliveira MLW. Hanseníase. 5. ed. Rio de Janeiro: Di Livros; 2015. Aspectos Gerais da Hanseníase, Agente Etiológico, Transmissão, Patogenia, Classificação, Manifestação Clínica, Diagnóstico; pp. 1–172. [Google Scholar]

Han XY, Seo YH, Sizer KC, Schoberle T, May GS, Spencer JS, et al. A New Mycobacterium Species Causing Diffuse Lepromatous Leprosy. Am J Clin Pathol. 2008;130:856–864. [PubMed] [Google Scholar]

Han XY, Silva FJ. On the Age of Leprosy. PLoS Negl Trop Dis. 2014;8:e2544. [PMC free article] [PubMed] [Google Scholar]

Fine PE. Leprosy: the epidemiology of a slow bacterium. Epidemiol Rev. 1982;4:161–188. [PubMed] [Google Scholar]

Leininger JR, Donham KJ, Rubino MJ. Leprosy in a Chimpanzee: Morphology of the skin lesions and characterization of the organism. Vet Pathol. 1978;15:339–346. [PubMed] [Google Scholar]

Walsh GP, Meyers WM, Binford CH, Gerone PJ, Wolf RH, Leininger JR. Leprosy a zoonosis. Lepr Rev. 1981;52:77–83. [PubMed] [Google Scholar]

Moet FJ, Meima A, Oskam L, Richardus JH. Risk factors for the development of clinical leprosy among contacts, and their relevance for targeted interventions. Lepr Rev. 2004;75:310–326. [PubMed] [Google Scholar]

Truman RW, Singh P, Sharma R, Busso P, Rougemont J, Paniz-Mondolfi A, et al. Probable Zoonotic Leprosy in the Southern United States. N Engl J Med. 2011;364:1626–1633. [PMC free article] [PubMed] [Google Scholar]

Kerr-Pontes LR, Barreto ML, Evangelista CM, Rodrigues LC, Heukelbach J, Feldmeier H. Socioeconomic, environmental, and behavioral risk factors for leprosy in North-east Brazil: Results of a case-control study. Int J Epidemiol. 2006;35:994–1000. [PubMed] [Google Scholar]

World Health Organization . WHO Expert Committee on Leprosy. World Health Organization; 2012. pp. 1–61. Tech Rep Series. [PubMed] [Google Scholar]

Aguas JT. Bacteriologia. Valencia: Ed Valenciana; 1999. La lepra: pasado, presente y futuro; pp. 77–88. [Google Scholar]

Chemotherapy of leprosy for control programmes: report of a WHO study group. WHO: Geneva; 1982. Technical Report Series, 675. [PubMed] [Google Scholar]

Weekly epidemiological record . Relevé Épidémiologique Hebdomadaire. Vol. 32. WHO; 2013. pp. 337–348. 88th year. [PubMed] [Google Scholar]

World Health Organization leprosy elimination project: status report 2002. WHO: Geneva; 2003. [Google Scholar]

World Health Assembly resolutions and decisions; Forty-fourth World Health Assembly; Geneva. 6-16 May 1991; Geneva: World Health Organization; 1991. annexes. [Google Scholar]

Bobin P. Peut- on programmer l'éradication, l'élimination ou le contrôle d'une maladie infectieuse? L'exemple de la lèpre. Bull I' ALLF. 2005;16:3–8. [Google Scholar]

Rodrigues LC, Lockwood DJ. Leprosy now: epidemiology, progress, challenges, and research gaps. Lancet Infect Dis. 2011;11:464–470. [PubMed] [Google Scholar]

Fine PE. Reflections on the elimination of leprosy. Int J Lepr Other Mycobact Dis. 1992;60:71–80. [PubMed] [Google Scholar]

Penna ML, Temporão JG, Grossi MA, Penna GO. Leprosy control: knowledge shall not be neglected. J Epidemiol Community Health. 2011;65:473–474. [PubMed] [Google Scholar]

Scollard DM. Leprosy research declines, but most of the basic questions remain unanswered. Int J Lepr Other Mycobact Dis. 2005;73:25–27. [PubMed] [Google Scholar]